Age-adjusted antitumoral therapy based on the demonstration of increased apoptosis as a mechanism underlying the reduced malignancy of tumors in the aged

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1688, Issue 2, 2004, Pages 145-159

  Itzhaki, Orit ^a   Kaptzan, Tatiana ^a   Skutelsky, Ehud ^a   Sinai, Judith ^a   Michowitz, Moshe ^a   Siegal, Annette ^a   Schibi, Ginnette ^a   Huszar, Monica ^a   Ben Dor, Lya ^a   Leibovici, Judith ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Age dependent therapy design; Aging; Apoptosis induction; Cancer treatment; Tumor progression

Indexed keywords

DOXORUBICIN; HYDROCORTISONE;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; LYMPHOMA; MELANOMA; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR CELL DESTRUCTION;

EID: 10744231700     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2003.11.009     Document Type: Article

References (56)

1. Ershler W.B. Why tumors grow more slowly in old people. J. Natl. Cancer Inst. 77:1986;837-839.
2. Ershler W.B., Stewart J.A., Hacker M.P., Moore A.L., Tindle B.H. B16 murine melanoma and aging: slower growth and longer survival in old mice. J. Natl. Cancer Inst. 72:1984;161-164.
3. Ershler W.B., Socinski M.A., Greene C.J. Bronchogenic cancer, metastases, and aging. J. Am. Geriatr. Soc. 31:1983;673-676.
4. Fisher C.J., Egan M.K., Smith P., Wicks K., Millis R.R., Fentiman I.S. Histopathology of breast cancer in relation to age. Br. J. Cancer. 75:1997;593-596.
5. Calabrese C.T., Adam Y.G., Volk H. Geriatric colon cancer. Am. J. Surg. 125:1973;181-184.
6. Tsuda T., Kim Y.T., Siskind G.W., DeBlasio A., Schwab R., Ershler W., Weksler M.E. Role of the thymus and T-cells in slow growth of B16 melanoma in old mice. Cancer Res. 47:1987;3097-3100.
7. Peto R., Roe F.J., Lee P.N., Levy L., Clack J. Cancer and ageing in mice and men. Br. J. Cancer. 32:1975;411-426.
8. Donin N., Sinai J., Staroselsky A., Mahlin T., Nordenberg J., Leibovici J. Comparison of growth rate of two B16 melanomas differing in metastatic potential in young versus middle-aged mice. Cancer Investig. 15:1997;416-421.
9. Donin N., Sinai J., Michowitz M., Hiss J., Nordenberg J., Leibovici J. Role of immune response as determinant of tumor progression in function of host age in the B16 melanoma. Mech. Ageing Dev. 80:1995;121-137.
10. Itzhaki O., Skutelsky E., Kaptzan T., Siegal A., Michowitz M., Sinai J., Huszar M., Nafar S., Leibovici J. Macrophage-recognized molecules of apoptotic cells are expressed at higher levels in AKR lymphoma of aged as compared to young mice. Adv. Exp. Med. Biol. 479:2000;251-262.
11. Cameron I.L. Cell proliferation and renewal in aging mice. J. Gerontol. 27:1972;162-172.
12. Tsuji Y., Ide T., Ishibashi S., Nishikawa K. Loss of responsiveness in senescent human TIG-1 cells to the DNA synthesis-inducing effect of various growth factors. Mech. Ageing Dev. 27:1984;219-232.
13. Kaesberg P.R., Ershler W.B. The importance of immunesenescence in the incidence and malignant properties of cancer in hosts of advanced age. J. Gerontol. 44:1989;63-66.
14. Takeichi N., Li X.B., Hamada J., Kobayashi H. Age-related decrease of pulmonary metastasis of rat mammary carcinoma by activated natural resistance. Cancer Immunol. Immunother. 31:1990;81-85.
15. Katz E.B., Boylan E.S. Stimulatory effect of high polyunsaturated fat diet on lung metastasis from the 13762 mammary adenocarcinoma in female retired breeder rats. J. Natl. Cancer Inst. 79:1987;351-358.
16. Yuhas J.M., Ullrich R.L. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum. Cancer Res. 36:1976;161-166.
17. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
18. Hickman J.A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11:1992;121-139.
19. Guchelaar H.J., Vermes A., Vermes I., Haanen C. Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm. World Sci. 19:1997;119-125.
20. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57:1999;727-741.
21. Elmore L.W., Rehder C.W., Di X., McChesney P.A., Jackson-Cook C.K., Gewirtz D.A., Holt S.E. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J. Biol. Chem. 277:2002;35509-35515.
22. Ling Y.H., Priebe W., Perez-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res. 53:1993;1845-1852.
23. Skladanowski A., Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem. Pharmacol. 46:1993;375-382.
24. Zaleskis G., Berleth E., Verstovsek S., Ehrke M.J., Mihich E. Doxorubicin-induced DNA degradation in murine thymocytes. Mol. Pharmacol. 46:1994;901-908.
25. Watts G.S., Futscher B.W., Isett R., Gleason-Guzman M., Kunkel M.W., Salmon S.E. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J. Pharmacol. Exp. Ther. 299:2001;434-441.
26. Boumpas D.T., Chrousos G.P., Wilder R.L., Cupps T.R., Balow J.E. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119:1993;1198-1208.
27. Moreau P., Harousseau J.L., Wijdenes J., Morineau N., Milpied N., Bataille R. A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma. Br. J. Haematol. 109:2000;661-664.
28. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
29. Iwata M., Hanaoka S., Sato K. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/ CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur. J. Immunol. 21:1991;643-648.
30. Leibovici J., Susskind-Brudner G., Wolman M. Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice. J. Natl. Cancer Inst. 65:1980;391-396.
31. Vindelov L.L., Christensen I.J., Nissen N.I. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry. 3:1983;328-331.
32. Veis D.J., Sentman C.L., Bach E.A., Korsmeyer S.J. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151:1993;2546-2554.
33. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br. J. Cancer. 35:1977;1-39.
34. Baroja A., de la Hoz C., Alvarez A., Vielba R., Sarrat R., Arechaga J., de Gandarias J.M. Polyploidization and exit from cell cycle as mechanisms of cultured melanoma cell resistance to methotrexate. Life Sci. 62:1998;2275-2282.
35. Kerbel R.S., Man M.S., Dexter D. A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice. J. Natl. Cancer Inst. 72:1984;93-108.
36. Heaton K.M., Rippon M.B., el-Naggar A., Tucker S.L., Ross M.I., Balch C.M. Prognostic implications of DNA index in patients with stage III cutaneous melanoma. Am. J. Surg. 166:1993;648-652.
37. Kay S., Donin N., Michowitz M., Katzenelson D., Hiss J., Schibi G., Pinchassov A., Leibovici J. Release from apoptosis correlates with tumor progression in the AKR lymphoma. Biochim. Biophys. Acta. 1497:2000;37-50.
38. Majno G., Joris I. Apoptosis, oncosis, and necrosis, An overview of cell death. Am. J. Pathol. 146:1995;3-15.
39. Frasci G. Chemotherapy of lung cancer in the elderly. Crit. Rev. Oncol./Hematol. 41:2002;349-361.
40. Balducci L. The geriatric cancer patient: equal benefit from equal treatment. Cancer Control. 8:2001;1-25.
41. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Hee P.S., Thompson T., Karsenty G., Bradley A., Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53.
42. Campisi J. Cancer and ageing: rival demons? Nat. Rev., Cancer. 3:2003;339-349.
43. Zhang Y., Herman B. Ageing and apoptosis. Mech. Ageing Dev. 123:2002;245-260.
44. Muskhelishvili L., Hart R.W., Turturro A., James S.J. Age-related changes in the intrinsic rate of apoptosis in livers of diet-restricted and ad libitum-fed B6C3F1 mice. Am. J. Pathol. 147:1995;20-24.
45. Itzhaki O., Skutelsky E., Kaptzan T., Sinai J., Michowitz M., Huszar M., Leibovici J. Aging-apoptosis relation in normal murine tissues. Mech. Ageing Dev. 124:2003;999-1012.
46. LoSchiavo F., Baldan B., Compagnin D., Ganz R., Mariani P., Terzi M. Spontaneous and induced apoptosis in embryogenic cell cultures of carrot (Daucus carota L.) in different physiological states. Eur. J. Cell Biol. 79:2000;294-298.
47. Hannun Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 89:1997;1845-1853.
48. Sharma K., Wang R.X., Zhang L.Y., Yin D.L., Luo X.Y., Solomon J.C., Jiang R.F., Markos K., Davidson W., Scott D.W., Shi Y.F. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol. Ther. 88:2000;333-347.
49. Distelhorst C.W., Dubyak G. Role of calcium in glucocorticosteroid- induced apoptosis of thymocytes and lymphoma cells: resurrection of old theories by new findings. Blood. 91:1998;731-734.
50. Smets L.A., Salomons G., van den Berg J. Glucocorticoid induced apoptosis in leukemia. Adv. Exp. Med. Biol. 457:1999;607-614.
51. Kofler R. The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells. Histochem. Cell Biol. 114:2000;1-7.
52. Zheng T.S., Hunot S., Kuida K., Momoi T., Srinivasan A., Nicholson D.W., Lazebnik Y., Flavell R.A. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat. Med. 6:2000;1241-1247.
53. Yen S.S., Laughlin G.A. Aging and the adrenal cortex. Exp. Gerontol. 33:1998;897-910.
54. Bruunsgaard H., Andersen-Ranberg K., Jeune B., Pedersen A.N., Skinhoj P., Pedersen B.K. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 54:1999;M357-M364.
55. Zakeri Z., Lockshin R.A. Physiological cell death during development and its relationship to aging. Ann. N.Y. Acad. Sci. 719:1994;212-229.
56. Smets L.A. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-cancer Drugs. 5:1994;3-9.